Li Wan-Qi, Cheng Ivy, Sasegbon Ayodele, Dai Meng, Hamdy Shaheen
Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Centre for Gastrointestinal Sciences, Faculty of Biology, Medicine and Health, Salford Royal Foundation Trust, University of Manchester, Manchester, UK.
Department of Rehabilitation Medicine, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
J Oral Rehabil. 2025 Jul 22. doi: 10.1111/joor.70025.
Thickened liquids have been one of the cornerstones of routine care to reduce aspiration for dysphagic patients in clinical practice. However, the evidence of this practice remains limited and uncertain.
This study aimed to systematically review and evaluate the effects of thickened liquid for adults with neurogenic dysphagia.
Five electronic databases were searched (Pubmed, Embase via Ovid, CINAHL, Web of Science and Cochrane Library) from each database's inception date until 30th July 2024. Search terms included a combination of database-specific controlled vocabulary terms and free-text terms relating to 'dysphagia' and 'thickened food'. Study inclusion criteria focused on peer-reviewed published articles including randomised controlled trials (RCT), cohort studies, case-control studies and case series. Only studies with neurogenic data were included. Four reviewers independently performed the search, data extraction and analysis. The outcome measure was a change in (any) relevant clinical swallowing-related characteristic.
A total of 2090 studies were identified, of which 16 met the inclusion criteria and were included in the review. The risk of bias of studies was moderate to low. Five studies either focused exclusively on different components of swallowing physiology or were unable to provide sufficient or reliable data for analysis and were thus excluded from data synthesis. Data analysis was conducted between groups (thin liquid vs. thickened liquid) concerning penetration (n = 5) and aspiration (n = 8), Penetration Aspiration Scale (PAS) scores (n = 4), unsafe swallowing (n = 7) and residue (n = 5). The results showed that thickened liquids improved swallowing safety, including reductions in aspiration events (([95% CI] = 0.49 [0.28, 0.88]; p = 0.02; I = 81%) in RCTs and ([95% CI] = 0.31 [0.13, 0.71]; p = 0.006; I = 47%) in non-RCTs), as well as improvements in unsafe swallowing ([95% CI] = 0.27 [0.14, 0.51]; p < 0.0001; I = 88%) and PAS scores ([95% CI] = -1.99 [-2.59, -1.38]; p < 0.00001; I = 89%). However, thickened liquids did not demonstrate a significant effect in reducing penetration events ([95% CI] = 0.40 [0.13, 1.22]; p = 0.11; I = 88%) and were associated with increased residue in both the pharynx ([95% CI] = 1.57 [1.20, 2.06]; p = 0.001; I = 16%) and the oral cavity ([95% CI] = 2.87 [1.88, 4.40]; p < 0.0001; I = 45%).
The current evidence, based mainly on non-randomised controlled trials, suggests that thickeners may help improve swallowing safety for neurogenic dysphagia, but this evidence remains weak. Further RCT evidence is needed to validate the clinical efficacy of thickeners.
INPLASY International Platform for Registered Systematic Reviews and Meta Analyses Program: INPLASY202510011.
在临床实践中,增稠液体一直是减少吞咽困难患者误吸的常规护理基石之一。然而,这种做法的证据仍然有限且不确定。
本研究旨在系统评价和评估增稠液体对成人神经性吞咽困难的影响。
检索了五个电子数据库(PubMed、通过Ovid检索的Embase、CINAHL、科学网和Cochrane图书馆),检索时间从每个数据库的起始日期至2024年7月30日。检索词包括特定数据库的受控词汇术语和与“吞咽困难”和“增稠食物”相关的自由文本术语的组合。研究纳入标准侧重于同行评审发表的文章,包括随机对照试验(RCT)、队列研究、病例对照研究和病例系列。仅纳入有神经性数据的研究。四位评审员独立进行检索、数据提取和分析。结局指标是(任何)相关临床吞咽相关特征的变化。
共识别出2090项研究,其中16项符合纳入标准并纳入综述。研究的偏倚风险为中度至低度。五项研究要么专门关注吞咽生理的不同组成部分,要么无法提供足够或可靠的数据进行分析,因此被排除在数据合成之外。在组间(稀液体与增稠液体)进行了关于渗透(n = 5)、误吸(n = 8)、渗透误吸量表(PAS)评分(n = 4)、不安全吞咽(n = 7)和残留(n = 5)的数据分析。结果表明,增稠液体提高了吞咽安全性,包括减少误吸事件(RCT中[95%置信区间] = 0.49 [0.28, 0.88];p = 0.02;I = 81%,非RCT中[95%置信区间] = 0.31 [0.13, 0.71];p = 0.006;I = 47%),以及改善不安全吞咽([95%置信区间] = 0.27 [0.14, 0.51];p < 0.0001;I = 88%)和PAS评分([95%置信区间] = -1.99 [-2.59, -1.38];p < 0.00001;I = 89%)。然而,增稠液体在减少渗透事件方面未显示出显著效果([95%置信区间] = 0.40 [0.13, 1.22];p = 0.11;I = 88%),并且与咽部([95%置信区间] = 1.57 [1.20, 2.06];p = 0.001;I = 16%)和口腔([95%置信区间] = 2.87 [1.88, 4.40];p < 0.0001;I = 45%)中残留的增加有关。
目前的证据主要基于非随机对照试验,表明增稠剂可能有助于提高神经性吞咽困难患者的吞咽安全性,但该证据仍然薄弱。需要进一步的RCT证据来验证增稠剂的临床疗效。
INPLASY国际注册系统评价和荟萃分析平台计划:INPLASY202510011。